Thyroid Cancer: Pathogenesis, Clinicopathology, Diagnosis, and Management

Area of Science:

• Endocrinology
• Oncology
• Pathology

Background:

• Thyroid cancer is the most common endocrine malignancy, with increasing global incidence.
• While most types have good prognoses, aggressive subtypes like anaplastic thyroid cancer present significant survival challenges.
• Overdiagnosis and overtreatment remain critical issues despite diagnostic advancements.

Purpose of the Study:

• To provide a comprehensive review of thyroid cancer pathogenesis, classification, and diagnostics.
• To explore evolving therapeutic strategies, including active surveillance, targeted therapy, and immunotherapy.
• To emphasize the role of precision medicine in personalized thyroid cancer care.

Main Methods:

• Review of current literature on thyroid cancer diagnostics and management.
• Analysis of advancements in high-resolution ultrasound and fine-needle aspiration biopsy.
• Integration of molecular profiling and risk stratification systems (e.g., Thyroid Imaging Reporting and Data System).

Main Results:

• Diagnostic tools have transformed thyroid cancer management, improving risk stratification.
• Precision medicine, integrating molecular data, can reduce treatment burden and enhance outcomes.
• Distinguishing indolent nodules from aggressive subtypes is crucial for effective management.

Conclusions:

• Continued refinement of diagnostic criteria and therapeutic frameworks is essential.
• Personalized care guided by molecular diagnostics and conventional parameters is key to improving thyroid cancer outcomes.
• Advances in understanding thyroid cancer biology are driving more effective treatment strategies.